Key points:
·The American company Altria Group has signed a non-binding Global Cooperation Memorandum of Understanding with the tobacco and consumer goods company KT&G to jointly explore growth opportunities in modern oral nicotine products, non-nicotine products, and optimize traditional tobacco operations.
·Altria's subsidiary acquired shares in the Nordic nicotine pouch company ASF during KT&G's acquisition, and also plans to expand the "on!" and "on! PLUS" products to specific countries with detailed strategies.
·Additionally, Altria's subsidiary has partnered with KT&G's Korean Ginseng Corporation (KGC) to focus on energy and health products, combining KGC's product capabilities with Altria's market resources to explore opportunities.
Altria Group announced on September 23, 2025, that they have signed a non-binding Global Cooperation Memorandum of Understanding with Korean tobacco and consumer goods company, KT&G Corporation. According to Altria, the agreement aims to leverage complementary strengths and resources to seek long-term growth opportunities in modern nicotine and non-nicotine products, and to enhance the operational efficiency of traditional tobacco business.
The memorandum is in line with Altria's strategic goal announced in March 2023, which is to seek long-term growth opportunities in the international innovative non-smoke and non-nicotine product sectors.
According to the agreement, KT&G and Altria will jointly acquire 100% of the shares of Scandinavian-based nicotine pouch manufacturer Another Snus Factory (ASF) for approximately 262.4 billion Korean won (approximately 197 million USD), with KT&G contributing approximately 160.5 billion Korean won (approximately 120 million USD) for a 51% stake and Altria holding the remaining 49%.
Altria and KT&G will explore collaboration opportunities to expand the demand for nicotine pouch products globally. Potential initiatives may include promoting the "on!" and "on! PLUS" product line in specific countries and engaging in strategic deals in the field of modern oral products.
A subsidiary of Altria and a subsidiary of KT&G, Korea Ginseng Corporation (KGC), will collaborate in exploring partnership opportunities in the United States, focusing on the energy and health products sector. In addition to innovating nicotine and non-nicotine products, Altria and KT&G have also agreed to collaborate on methods to optimize the traditional tobacco product operations process.
Altria CEO Billy Gifford expressed his excitement to collaborate with KT&G, leveraging its strengths in innovative nicotine and non-nicotine products to grow together. KT&G CEO Kyung-man Bang stated that this partnership will expand the business scope from cigarettes to nicotine pouches and other areas, opening up a growth path for the next generation of tobacco products.
Cover source provided by KT&G.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
